上一条： Discovery of novel NSAID hybrids as cPLA(2)/COX-2 dual inhibitors alleviating rheumatoid arthritis via inhibiting p38 MAPK pathway.

下一条： Novel trifluoromethyl ketone derivatives as oral cPLA(2)/COX-2 dual inhibitors for resolution of inflammation in rheumatoid arthritis.